Actively Recruiting
Opioid Management for Discharged Emergency Department Patients
Led by Addinex Technologies, Inc. · Updated on 2025-12-26
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
A
Addinex Technologies, Inc.
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to patients.
CONDITIONS
Official Title
Opioid Management for Discharged Emergency Department Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages six years and older
- Ability to swallow pills
- Isolated bone fracture
- Planned to receive opioids in the post-treatment period
- Not taking opioids daily prior to the procedure
- English or Spanish-speaking
- Able to give informed consent or a parent that can give informed consent
- Ownership of and comfort using apps on a smartphone with compatible operating system
- WIFI or cellular access
- Patient not admitted to hospital
You will not qualify if you...
- Recent opioid use (last 30 days or 2 or more prescriptions in the past 3 months)
- Impaired decisional capacity
- In police custody
- Ward of the state
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rhode Island Hospital/Lifespan
Providence, Rhode Island, United States, 02903
Actively Recruiting
Research Team
G
Geoffrey Capraro, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here